A specific method for the measurement of cyclosporin A in human whole blood by liquid chromatography-tandem mass spectrometry

Therapeutic Drug Monitoring

Volumn 20, Issue 3, 1998, Pages 294-300

  Simpson, Janice ^a   Zhang, Qingling ^a   Ozaeta, Panfilo ^a   Aboleneen, Hoda ^a,b  

^a ABBOTT DIAGNOSTICS   (United States)

^b D90T AP 20 ^*  (United States)

Author keywords

High performance liquid chromatography tandem mass spectrometry; Immunosuppressive drugs; Metabolites; Organ transplantation

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN C; DRUG METABOLITE;

ACCURACY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; GRAFT REJECTION; GRAFT SURVIVAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MASS SPECTROMETER; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY;

EID: 0031840258     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199806000-00009     Document Type: Article

References (20)

1. Oellerich M, Armstrong V, Kahn B, et al. Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995;17:642-54.
2. Favre H, Miescher PA, Lemoine R. Use of cyclosporin in the treatment of autoimmune disorders. Transplant Proc 1994;26: 3194-6.
3. Furlanut M, Baraldo M, Pea F, Marzocchi V, Croattino L, Galla F. Blood concentrations and clinical effect of cyclosporin in psoriasis. Ther Drug Monit 1996;18:544-8.
4. Holt D, Johnston A, Roberts N, Tredger JM. Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force. Ann Clin Biochem 1994; 31:420-46.
5. Büttner J, Borth R, Boutwell HJ, Broughton PMG, Bowyer RC. Approved recommendation (1978) on quality control in clinical chemistry, Part 2: Assessment of analytical methods for routine use. J Clin Chem Clin Biochem 1980;18:78-88.
6. Maurer G, Loosli HR, Schreier E, Keller B. Disposition of cyclosporin in several animal species and man, I: Structural elucidation of its metabolites. Drug Metab Dispos 1984;12:120-6.
7. Hartmann NR, Jardine I. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporin metabolites. Drug Metab Dispos 1987;15:661-4.
8. Cheung F, Wong PY, Loo J, Cole EH, Levy GA. Identification of cyclosporin metabolites in human bile, blood, and urine by high-performance liquid chromatography/radioimmunoassay/fast atomic bombardment mass spectroscopy. Transplant Proc 1988;(suppl 2):20;602-8.
9. Bowers LD, Norman DD, Yan X-X, Scheeler D, Carlson KL. Isolation and structural identification of 9hydroxy-9desmethyl-cyclosporin. Clin Chem 1990;36:1875-9.
10. Christians U, Strohmeyer S, Kownatzki R, et al. Investigations on the metabolic pathways of cyclosporin, I: Excretion of cyclosporin and its metabolites in human bile - isolation of 12 new cyclosporin metabolites. Xenobiotica 1991;21:1185-98.
11. Bowers LD, Norman DD, Henion JD. Isolation and characterization of cyclosporin metabolites using high-performance liquid chromatography and tandem mass spectrometry. Transplant Proc 1988;(suppl 2):20;597-601.
12. Abián J, Stone A,Morrow MG, Creer MH,Fink LM, Lay JO Jr. Thermospray high-performance liquid chromatography/mass spectrometric determination of cyclosporins. Rapid Commun Mass Spectrom 1992;6:684-9.
13. Muddiman DC, Gusesv AI, Prosctor A, Hercules DM, Venkataramanan R, Diven W. Quantitative measurement of cyclosporin A in blood by time-of-flight mass spectrometry. Anal Chem 1994;66: 2362-8.
14. Muddiman DC, Gusev AI, Stoppeck-Langner K, et al. Simultaneous quantification of cyclosporin A and its major metabolites by time-of-flight secondary-ion mass spectrometry and matrix-assisted laser desorption/ionization mass spectrometry utilizing data analysis techniques: comparison with high-performance liquid chromatography. J Mass Spectrom 1995;30:1469-79.
15. Allen MH, Shushan BI. Atmospheric pressure ionization-mass spectrometry detection for liquid chromatography and capillary electrophoresis. LC-GC 1993;11:112-24.
16. Taylor P, Jones A, Balderson G, Lynch S, Norris R, Pond S. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. Ther Drug Monit 1996;42:279-85.
17. Zhang Q, Simpson J, Aboleneen H. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry. Ther Drug Monit 1997; 19:470-6.
18. Whitman DA, Abbott V, Fregien K, Bowers LD. Recent advances in high-performance liquid chromatography/mass spectrometry and high-performance liquid chromatography/tandem mass spectrometry: detection of cyclosporin and metabolites in kidney and liver tissue. Ther Drug Monit 1993;15:552-6.
19. Kebarle P, Tang L. From ions in solution to ions in the gas phase: the mechanism of electrospray mass spectrometry. Anal Chem 1993;65:972A-86A.
20. Schindler PA, Van Dorsselaer A, Falick AM. Analysis of hydrophobic proteins and peptides by electrospray ionization mass spectrometry. Anal Biochem 1993;213:256-63.